References
Oct 1, 1987·European Journal of Clinical Investigation·Y A Kesäniemi, T A Miettinen
Jan 20, 1984·JAMA : the Journal of the American Medical Association
Nov 16, 1995·The New England Journal of Medicine·T A MiettinenE Vartiainen
Nov 26, 1999·The Journal of Nutrition·T T Nguyen
Mar 1, 2000·Archives of Internal Medicine·T A PearsonS Kafonek
Nov 1, 2000·Circulation·V PasceriE T Yeh
Nov 22, 2000·Current Opinion in Lipidology·J PlatR P Mensink
Feb 27, 2001·Circulation·A H Lichtenstein, R J Deckelbaum
Jun 30, 2001·The New England Journal of Medicine·P M RidkerUNKNOWN Air Force/Texas Coronary Atherosclerosis Prevention Study Investigators
Jul 7, 2001·Clinical Therapeutics·F EzzetV K Batra
Sep 18, 2001·Clinical Therapeutics·H E BaysUNKNOWN Ezetimibe Study Group
Sep 21, 2001·British Journal of Pharmacology·M van HeekH R Davis
May 30, 2002·Circulation·Claude GagnéUNKNOWN Ezetimibe Study Group
Jul 13, 2002·Lancet·UNKNOWN Heart Protection Study Collaborative Group
Aug 21, 2002·Circulation·Richard C PasternakUNKNOWN National Heart, Lung and Blood Institute
Oct 9, 2002·Circulation·Thomas SudhopKlaus von Bergmann
Nov 9, 2002·The American Journal of Cardiology·Claude GagnéUNKNOWN Ezetimibe Study Group
Nov 9, 2002·The American Journal of Cardiology·Carlos A DujovneUNKNOWN Ezetimibe Study Group
Dec 31, 2002·Journal of the American College of Cardiology·Michael H DavidsonEnrico P Veltri
Jan 29, 2003·Circulation·Paul M Ridker
Mar 8, 2003·Preventive Cardiology·Stephen D Turley, John M Dietschy
Apr 1, 2003·Circulation·Chao-Hung WangSubodh Verma
Apr 30, 2003·Circulation·Christie M BallantyneUNKNOWN Ezetimibe Study Group
Feb 21, 2004·Science·Scott W AltmannMichael P Graziano
Jun 15, 2004·The American Journal of Cardiology·Christie M BallantyneJoanne Palmisano
Jul 14, 2004·Circulation·Scott M GrundyUNKNOWN American Heart Association
Mar 10, 2005·The New England Journal of Medicine·John C LaRosaUNKNOWN Treating to New Targets (TNT) Investigators
Nov 17, 2005·JAMA : the Journal of the American Medical Association·Terje R PedersenUNKNOWN Incremental Decrease in End Points Through Aggressive Lipid Lowering (IDEAL) Study Group
Citations
Jun 1, 2006·Expert Review of Neurotherapeutics·Walter J Lukiw
Jun 10, 2008·Expert Opinion on Emerging Drugs·Walter J Lukiw
Mar 24, 2012·Expert Opinion on Emerging Drugs·Walter J Lukiw
Jan 18, 2015·Indian Heart Journal·K Sarat ChandraSeema Gulati
Jul 29, 2006·Pharmacology & Therapeutics·Irina A Pikuleva